TP53 and ovarian carcinoma: In the present study of SDCs—as has been demostrated in breast [36] and ovarian carcinomas [37–39]—we proved that extreme p53 positivity and negativity was associated with TP53 missense and truncating mutations, respectively; this possibility has been suggested previously [11, 14].